Taken together, our results show that we have identified the YB-1/CCT4/mLST8/mTOR axis as a contributor to glioblastoma growth and suggest a therapeutic approach to target this axis using competitive RNA oligonucleotides. The gene discussed is MLST8; the disease is glioblastoma.